Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Matthew on +44 1494 818 054 or matthew@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Matthew Moxon
Account Manager
matthew@zenopa.com
+44 1494 818 054

Testimonials
I feel compelled to thank you for the service that you provided me with over the last two years. I found everyone that I dealt with to be very professional and efficient but always appreciated the hum...
Neil, 2011

Boston Scientific launches new Mustang PTA balloon catheter

23 June 2011 00:00 in Medical Company Product News


Boston Scientific has launched a new balloon catheter for use in percutaneous transluminal angioplasty (PTA) worldwide.

Available now in the US, Europe and other international markets, the Mustang device is a highly deliverable 0.035-inch unit that has been designed in response to demand for a low-profile, high-pressure balloon catheter in a range of sizes.

It utilises Boston Scientific's NyBax Balloon Material to provide high-pressure, non-compliant dilatation, excellent rated burst pressure and compatibility with a 5 French introducer sheath.

The manufacturer states that the Mustang device, which is available in 203 size variants, will be applicable to a variety of lesions of different complexities.

Joe Fitzgerald, senior vice-president and president of Boston Scientific's endovascular unit, said: "Its versatility and extensive size matrix allow physicians to address nearly every peripheral need, ranging from treating blockages in femoral arteries to dialysis fistulae."

This follows on from the launch of its Energen and Punctua cardiac resynchronisation therapy defibrillators and implantable cardioverter defibrillators in Europe last month.ADNFCR-8000103-ID-800597505-ADNFCR

Other news stories from 23/06/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd